A Safety, Tolerability, Efficacy and Exposure Study of XEN801 Topical Gel

NCT02656043 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

213

Enrollment

INDUSTRY

Sponsor class

Conditions

Acne Vulgaris

Interventions

DRUG: XPF-005
DRUG: Placebo

Sponsor

Xenon Pharmaceuticals Inc.